Exploring pharmacokinetic variability of palbociclib in HR+/HER2- metastatic breast cancer: a focus on age, renal function, and drug-gene interactions.

Front Pharmacol · 2024 · PMC11412846 · PMID 39309010

Europe PMC DOI

hedged sentence

0.0581

closest p · 1.2× alpha

0.0581

boldest claim

The sentences

did not reach statistical significancep = 0.0581so close (0.05 < p ≤ 0.1)

Although a similar trend was observed in relation to the menopausal status, it did not reach statistical significance ( p = 0.0581).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.